Evidence map›Paper›PMID 19117988›Full record

ArticleCancer research2009

A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.

Ezra E W Cohen, Hongyan Zhu, Mark W Lingen, Leslie E Martin, Wen-Liang Kuo, Eugene A Choi, Masha Kocherginsky, Joel S Parker, Christine H Chung, Marsha Rich Rosner

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  8. Deiodinases and Cancer.Endocrinology · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ezra E W CohenSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Hongyan Zhu
Mark W Lingen
Leslie E Martin
Wen-Liang Kuo
Eugene A Choi
Masha Kocherginsky
Joel S Parker
Christine H Chung
Marsha Rich Rosner
May Institute · USUniversity of Chicago · USVanderbilt University · US

Funding

ORAL CANCER, RETINOIDS, AND ANTIANGIOGENESISR01DE012322 · NIDCR · UNIVERSITY OF CHICAGO · PI LINGEN, MARK W. · 1998 to 2009
$2.3M
Molecular signatures of HNSCC in response to targeted therapiesR01DE017982 · NIDCR · VANDERBILT UNIVERSITY · PI CHUNG, CHRISTINE H · 2007 to 2011
$1.9M
REHABILITATION OF ORAL CANCER PATIENTS AND BEHAVIOR MODIFICATIONP50DE011921 · NIDCR · UNIVERSITY OF CHICAGO · PI THOMPSON, CRAIG B · 1996 to 2001
$1.3M
Modulation of Head and Neck Cancer by Protein Kinase CR01CA109278 · NCI · UNIVERSITY OF CHICAGO · PI ROSNER, MARSHA R · 2004 to 2008
$1.2M
MOLECULAR DETERMINANTS OF ANGIOGENSIS IN ORAL CANCERK02DE000470 · NIDCR · UNIVERSITY OF CHICAGO · PI LINGEN, MARK W. · 2001 to 2005
$600k
NCI NIH HHS R01 CA109278NCI NIH HHS R01 CA 109278-01NIDCR NIH HHS DE 00470NIDCR NIH HHS DE 12322NIDCR NIH HHS K02 DE000470NIDCR NIH HHS P50 DE 11921-05S1NIDCR NIH HHS R01 DE012322NIDCR NIH HHS R01 DE017982NIDCR NIH HHS R01 DE 017982-01
6 · The paper itself

Abstract

Protein kinase Calpha (PKCalpha) has been implicated in cancer, but the mechanism is largely unknown. Here, we show that PKCalpha promotes head and neck squamous cell carcinoma (SCCHN) by a feed-forward network leading to cell cycle deregulation. PKCalpha inhibitors decrease proliferation in SCCHN cell lines and xenografted tumors. PKCalpha inhibition or depletion in tumor cells decreases DNA synthesis by suppressing extracellular signal-regulated kinase phosphorylation and cyclin E synthesis. Additionally, PKCalpha down-regulates miR-15a, a microRNA that directly inhibits protein synthesis of cyclin E, as well as other cell cycle regulators. Furthermore, both PKCalpha and cyclin E protein expression are increased in primary tumors, and PKCalpha inversely correlates with miR-15a expression in primary tumors. Finally, PKCalpha is associated with poor prognosis in SCCHN. These results identify PKCalpha as a key regulator of SCCHN tumor cell growth by a mechanism involving activation of mitogen-activated protein kinase, an initiator of the cell cycle, and suppression of miR-15a, an inhibitor of DNA synthesis. Although the specific components may be different, this type of feed-forward loop network, consisting of a stimulus that activates a positive signal and removes a negative brake, is likely to be a general one that enables induction of DNA synthesis by a variety of growth or oncogenic stimuli.

Indexed as

AnimalsCarcinoma, Squamous CellCell CycleCell Cycle ProteinsCell Growth ProcessesCyclin EDNA, NeoplasmFemaleGene ExpressionHead and Neck NeoplasmsHumansMiceMice, NudeMicroRNAsMouth MucosaProtein Kinase C-alphaCell Cycle ProteinsCyclin EDNA, NeoplasmMicroRNAsMIRN15 microRNA, humanProtein Kinase C-alpha

Identifiers

PMID19117988
PMCPMC2746005
OpenAlexW2112944159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.